Shares of United States Antimony Corporation (AMEX:UAMY) plummeted 5.12% in intraday trading on Thursday following the release of its third-quarter financial results, which fell short of analysts' expectations. The company also issued fiscal year 2025 sales guidance below market estimates, further dampening investor sentiment.
United States Antimony reported a loss of 4 cents per share for the third quarter, missing the consensus estimate of a 2 cents per share profit. Revenue came in at $8.70 million, significantly below the expected $12.86 million. Adding to the disappointment, the company provided a fiscal year 2025 sales outlook ranging from $40 million to $43 million, which falls short of the $46.38 million consensus estimate.
Despite the negative market reaction, U.S. Antimony highlighted some positive developments. The company reported substantial year-to-date growth in its broader operations, with increased revenue and gross profit for the first nine months of 2025. Notably, antimony sales rose due to higher average sales prices, and zeolite sales also increased. The company secured two major contracts recently: a five-year Defense Logistics Agency contract valued at up to $245 million and a five-year commercial supply agreement worth approximately $107 million. Additionally, U.S. Antimony reported progress at its recently reopened Montana mine and expects new supply to support future margin expansion. Looking ahead to fiscal year 2026, the company projects sales of $125 million, surpassing the current consensus estimate of $109.45 million.
Comments